articleJournal of Clinical InvestigationAug 1, 2003GREEN OA

The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

Medizinische Hochschule Hannover · Goethe University Frankfurt · +2 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Ectopic calcification is a frequent complication of many degenerative diseases. Here we identify the serum protein alpha2-Heremans-Schmid glycoprotein (Ahsg, also known as fetuin-A) as an important inhibitor of ectopic calcification acting on the systemic level. Ahsg-deficient mice are phenotypically normal, but develop severe calcification of various organs on a mineral and vitamin D-rich diet and on a normal diet when the deficiency is combined with a DBA/2 genetic background. This phenotype is not associated with apparent changes in calcium and phosphate homeostasis, but with a decreased inhibitory activity of the Ahsg-deficient extracellular fluid on mineral formation. The same underlying principle may…

Citation impact

904
total citations
FWCI
17.29
Percentile
100%
References
66
Citations per year

Authors

9

Topics & keywords

Keywords
  • Ectopic calcification
  • Fetuin
  • Calcification
  • Internal medicine
  • Endocrinology
  • Glycoprotein
  • Calcinosis
  • Medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding